OPDP Researchers To Examine Adherence and Preference Claims

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

OPDP Researchers To Examine Adherence and Preference Claims

J.W. Schomisch

October 18, 2023 at 08:27 AM EST

Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) plan to build upon earlier research on market claims and disclosures to explore the influence of statements around patient adherence and preference in prescription drug promotion. According to an announcement of the new research (88 Fed. Reg. 70669) “previous FDA-funded research showed market claims that ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

OPDP Researchers To Examine Adherence and Preference Claims

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT